BDBM50091755 (S)-N-[(S)-4-Guanidino-1-((S)-2-methyl-pentylcarbamoyl)-butyl]-3-[(2S,3S)-2-((S)-5-guanidino-2-phenylacetylamino-pentanoylamino)-3-methyl-pentanoylamino]-succinamic acid::CHEMBL435181

SMILES: CCC[C@H](C)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)Cc1ccccc1)[C@@H](C)CC

InChI Key: InChIKey=WNMJJSOJFSGNGI-GAXORZTASA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50091755   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Atrial natriuretic peptide receptor (Homo sapiens (Human))	BDBM50091755 ((S)-N-[(S)-4-Guanidino-1-((S)-2-methyl-pentylcarba...) Show SMILES CCC[C@H](C)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)Cc1ccccc1)[C@@H](C)CC Show InChI InChI=1S/C36H61N11O7/c1-5-12-22(3)21-43-31(51)25(15-10-17-41-35(37)38)45-33(53)27(20-29(49)50)46-34(54)30(23(4)6-2)47-32(52)26(16-11-18-42-36(39)40)44-28(48)19-24-13-8-7-9-14-24/h7-9,13-14,22-23,25-27,30H,5-6,10-12,15-21H2,1-4H3,(H,43,51)(H,44,48)(H,45,53)(H,46,54)(H,47,52)(H,49,50)(H4,37,38,41)(H4,39,40,42)/t22-,23-,25-,26-,27-,30-/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	539	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [125I]- ANP from the Atrial natriuretic peptide receptor A.				Bioorg Med Chem Lett 10: 1949-52 (2001) BindingDB Entry DOI: 10.7270/Q2BK1BKQ
					More data for this Ligand-Target Pair
Atrial natriuretic peptide receptor 3 (Homo sapiens (Human))	BDBM50091755 ((S)-N-[(S)-4-Guanidino-1-((S)-2-methyl-pentylcarba...) Show SMILES CCC[C@H](C)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)Cc1ccccc1)[C@@H](C)CC Show InChI InChI=1S/C36H61N11O7/c1-5-12-22(3)21-43-31(51)25(15-10-17-41-35(37)38)45-33(53)27(20-29(49)50)46-34(54)30(23(4)6-2)47-32(52)26(16-11-18-42-36(39)40)44-28(48)19-24-13-8-7-9-14-24/h7-9,13-14,22-23,25-27,30H,5-6,10-12,15-21H2,1-4H3,(H,43,51)(H,44,48)(H,45,53)(H,46,54)(H,47,52)(H,49,50)(H4,37,38,41)(H4,39,40,42)/t22-,23-,25-,26-,27-,30-/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	539	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [125I]- ANP from the Atrial Natriuretic Peptide Clearance Receptor.				Bioorg Med Chem Lett 10: 1949-52 (2001) BindingDB Entry DOI: 10.7270/Q2BK1BKQ
					More data for this Ligand-Target Pair